SLEEP HEALTH FOR PHARMACY
.webp)
From an everyday visit to an appropriate next step
were at high risk for obstructive sleep apnea
In a 2025 study across 22 Italian community pharmacies, 38.5% of participants were classified as being
at high risk for obstructive sleep apnea using the Berlin Questionnaire. Higher BMI and antihypertensive medication use were also associated with high-risk results.
Giombi et al., Frontiers in Public Health, 2025
Self-guided FaceX experience
FaceX combines a selfie-based facial analysis with a few health and sleep questions. Visitors complete the experience independently using their own phone, a pharmacy tablet, or a kiosk.
.webp)
A guided selfie and short questions add context about sleep, symptoms, and relevant health factors.
Choose a convenient time to
speak with a qualified sleep healthcare provider.
No staff introduction or scan administration is required. When appropriate, visitors can continue to a qualified healthcare provider.
FaceX supports early risk awareness and does not provide a diagnosis.
Your pharmacy selects where the experience appears. Visitors decide when they want to begin.
Place a QR display or information card near the prescription pickup area.
Make FaceX visible at another high-traffic pharmacy touchpoint.
Place it alongside existing clinical, medication, and wellness services.
Share FaceX through your website or pharmacy-approved patient communications.
Here are the questions that matter when you are deciding how Soliish could fit your pharmacy,
your partners, and your commercial model.
No. Visitors scan the QR code and complete FaceX independently using their own phones. A self-guided tablet or kiosk can also be used.
The visitor can be guided toward an appropriate provider for further evaluation. The pathway may use a connected provider, a pharmacy-preferred local provider, or the patient’s existing physician, depending on the operating model and patient choice.
FaceX provides risk awareness and next-step guidance. Qualified healthcare providers remain responsible for clinical evaluation, diagnosis, prescriptions, and treatment decisions.
The opportunity depends on the services your pharmacy retains, the pathways routed to partners, and the commercial model agreed upon before launch.
The workflow can be designed to keep the pharmacy appropriately connected across provider evaluation, treatment, and fulfillment, based on patient consent, privacy requirements, and partner responsibilities.
Before launch, Soliish works with the pharmacy and participating partners to define consent, privacy, escalation, follow-up, and operational responsibilities.
Your next step